Stocksigma LogoStocksigma Logo

KRM Ayurveda Reports Robust H1 FY27 Performance with 110% PAT Growth

KRM Ayurveda reported strong financial results for H1 FY27, with total income rising 40.10% YoY to ₹6,816.50 Lakhs

KRM Ayurveda Reports Robust H1 FY27 Performance with 110% PAT Growth

KRM Ayurveda Ltd · Investor Presentation · 15 Nov 2026, 12:43 am

KRM Ayurveda Reports Robust H1 FY27 Performance with 110% PAT Growth KRM Ayurveda reported strong financial results for H1 FY27, with total income rising 40.10% YoY to ₹6,816.50 Lakhs. Operating profitability expanded significantly, with EBITDA increasing 79.81% YoY to ₹2,382.40 Lakhs (margin up 772 bps to 34.95%) and PAT advancing 109.55% YoY to ₹1,723.09 Lakhs (margin up 838 bps to 25.28%). As of 30th Sep'26, the company operated 8 hospitals with 326 beds at 60% occupancy, achieving an ARPOB of ~₹8,400. Service revenue contributed 62.63% of H1 revenue, supported by network additions in Gurugram, Janakpuri, and Vashi.

Original exchange filing (PDF)

More announcements from KRM Ayurveda Ltd

All KRM Ayurveda Ltd announcements